Interact to see
Advertisement
Advertisement
BALPX vs CMRAX
BALPX vs CMRAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
BALPX vs. CMRAX commentary
Dec 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALPX is a Buy and CMRAX is a StrongBuy.
FUNDAMENTALS
Fundamentals
BALPX has more cash in the bank: 4.7B vs. CMRAX (2.76M). BALPX pays higher dividends than CMRAX: BALPX (4.06) vs CMRAX (1.05). BALPX was incepted earlier than CMRAX: BALPX (18 years) vs CMRAX (2 years). CMRAX (12.56) is less costly to investors than BALPX (1.60). CMRAX is a more actively managed with annual turnover of: 136.00 vs. BALPX (81.00). BALPX initial investment is less costly to investors than CMRAX (3%) vs CMRAX (3%). BALPX has a lower initial minimum investment than CMRAX: BALPX (1000) vs CMRAX (2500). CMRAX annual gain was more profitable for investors over the last year : 9.75 vs. BALPX (5.72).
| BALPX | CMRAX | BALPX / CMRAX | |
| Total Expense Ratio | 1.51 | 2.16 | 70% |
| Annual Report Gross Expense Ratio | 1.60 | 12.56 | 13% |
| Fund Existence | 18 years | 2 years | - |
| Gain YTD | 6.647 | 10.243 | 65% |
| Front Load | 5% | 3% | 191% |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.7B | 2.76M | 170,022% |
| Annual Yield % from dividends | 4.06 | 1.05 | 389% |
| Returns for 1 year | 5.72 | 9.75 | 59% |
| Returns for 3 years | 12.03 | N/A | - |
| Returns for 5 years | 11.60 | N/A | - |
| Returns for 10 years | 30.35 | -58.13 | -52% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NQVCX | 59.46 | 0.20 | +0.34% |
| Nuveen Multi Cap Value C | |||
| FFNIX | 14.37 | N/A | N/A |
| Fidelity Advisor Asset Manager 40% I | |||
| MLACX | 2.79 | N/A | N/A |
| NYLI Winslow Large Cap Growth Class C | |||
| OBEGX | 36.09 | -0.04 | -0.11% |
| Oberweis Global Opportunities Investor | |||
| TLGCX | 8.49 | -1.55 | -15.44% |
| Timothy Plan Large/Mid Cap Growth C | |||